Biotech · Private company · Dover, DE, US

Einsenca Inc.

Track this companyFree. Adds Einsenca Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Phase 0 Study to Evaluate the in vivo Characteristics of a Myeloperoxidase-Targeting PET Agent in Healthy Volunteers and Early AD PatientsFiscal year 2025 · $497.9KNIH RePORTER 1R43AG092066-01 · fetched Nov 12, 2026
PET Imaging of Damaging Neuroinflammation in Alzheimer's Disease Technical and Business Assistance (TABA)Fiscal year 2024 · $50KNIH RePORTER 3R44AG079734-02S1 · fetched Nov 12, 2026
PET Imaging of Damaging Neuroinflammation in Alzheimer's DiseaseFiscal year 2024 · $1.3MNIH RePORTER 5R44AG079734-03 · fetched Nov 12, 2026